Checked against public sources on August 6, 2026 · LookCloser does not sell or recommend supplements.
Does the marketing hold up?
The front says 700 mg under ashwagandha; the panel assigns 350 mg to it. The number that sold you is larger than the amount assigned to the named ingredient. Read the panel amount, not the front-label total.
“Couldn’t verify” means we looked and found no public proof — not a mark against the product. Most supplement claims cannot be independently verified by anyone, so grey is the normal state of this industry.
| Ashwagandha Powder (root) (Withania Somnifera) | 350 mg |
|---|---|
| Ashwagandha Root Extract (2.5% Wi thanolides) | 350 mg |
| Black Pepper Extract 4:1 | 2.6 mg |
Printed on the package: Natural Ingredients · Vegetarian Capsules · Non-GMO · Gluten Free · VEGETARIAN FRIENDLY · NON-GMO INGREDIENTS · NO ARTIFICIAL ADDITIVES
We read 3 lines from the package photograph. It is our transcript of the label, not the manufacturer’s panel, and it may be incomplete.
1 promise needs a closer look.
The listing uses 0.7 g for ashwagandha. The panel lists ashwagandha at 0.35 g; the other 350 mg is the rest of the listed blend. Panel addition: Ashwagandha Powder (root) (Withania Somnifera) 350 mg + Ashwagandha Root Extract (2.5% Wi thanolides) 350 mg = 700 mg. This documents the framing; it does not establish what is inside the product.
Published research exists for ingredients in this formula. Whether this product’s doses match those studies could not be confirmed.
Ingredient research can support context, but it is not a trial of this exact product.
MAXIMUM STRENGTH ASHWAGANDHA · 3-IN-1 ADVANCED FORMULA
Headlines first. Open evidence only when you want the source trail.
Every ingredient shows its real amount — nothing is hidden in a proprietary blend.
The panel gives a per-ingredient amount rather than hiding quantities inside a proprietary blend, so each one can be compared to published research.
Locked evidence record →Open the full source-linked findingA count that moves steadily is ordinary. A sudden burst is what deserves a closer look.
Written reviews rose from 0 to 1 between June 9 and July 8, 2026. The largest rise inside any single 30-day window was about 1, so the count moved in steps rather than in one burst.
Locked evidence record →Open the full source-linked findingThese are evidence gaps, not strikes against the product.
The label amount is shown beside the range used in the linked ingredient studies.
350 mg per serving — within the 250–600 mg/day used in the linked studies.
Not a score. Studies disagree with each other and change over time, so this sits beside the evidence rather than counting toward it — it is here so you can read the sources yourself.
The panel lists 350 mg of ashwagandha per serving. Studies we found used 250 mg–600 mg a day, so this sits inside that range.
Study ranges differ between trials and change as research changes. This is background reading, not a pass, a failure, or a recommendation.
Only the submitted seller page is identity-certain. Other destinations are shown as leads until a shared UPC/GTIN confirms the exact product.
Lowest New observed via Keepa on 2026-08-06.
View on Amazon ↗No matching product page was confirmed in the current record. Search results cannot be attached as this product until the UPC/GTIN matches.
Search iHerb ↗No matching product page was confirmed in the current record. Search results cannot be attached as this product until the UPC/GTIN matches.
Search Target ↗No matching product page was confirmed in the current record. Search results cannot be attached as this product until the UPC/GTIN matches.
Search Walmart ↗Prices and stock are point-in-time observations. Related pages are never used as product evidence. No affiliate links; LookCloser earns nothing from these sellers.
The full report shows every source, the exact unresolved question, and the documentation that would settle it.
Record built August 06, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.